科硏成果
Combined pyrotinib and fulvestrant for hormone receptor‐positive and HER2‐positive metastatic breast cancer: A multicenter, single‐arm, phase II trial
2024年12月发表于医学SCI期刊：MedComm (2020)
全文链接：https://pmc.ncbi.nlm.nih.gov/articles/PMC11661908/